What are the key takeaways from this This Week in Startups episode?

Key insights include: **Hemp Market Arbitrage:** The 2018 Farm Bill legalized hemp (cannabis with less than 0.3% THC), creating a loophole where companies extract and concentrate hemp-derived THC to match state-regulated potency levels. Hemp products avoid 280E tax restrictions, enable direct-to-consumer shipping, and allow social media advertising, making them significantly more profitable than state-regulated cannabis despite existing in a legal gray area.; **280E Tax Burden:** Cannabis companies cannot deduct business expenses under IRS code 280E because cannabis remains Schedule I, resulting in 70% effective tax rates versus typical corporate rates. Removing this restriction through federal rescheduling would make most cannabis businesses profitable overnight. State excise taxes add another 15-20% burden, pushing consumers toward illicit markets where California struggles with legal adoption.; **Market Consolidation Reality:** Cannabis industry funding peaked in 2021 at over $70 billion but has declined sharply since. The market shifted from growth-at-all-costs to profitability requirements. Success now means survival rather than rapid scaling. Companies that raised heavily for state-regulated markets before pivoting to hemp face significant dilution, creating acquisition opportunities for strategic buyers entering during this uncertainty period before potential federal rescheduling.

What did Ford Smith discuss on This Week in Startups?

Cannabis industry experts Ford Smith, Andrew Duffy, and Socrates Rosenfeld discuss the state of cannabis startups, regulatory challenges including Schedule I classification and 280E tax code, the hemp market loophole enabling national distribution, market consolidation since 2021, and prospects for federal rescheduling under Trump's second term affecting the $30 billion industry. Key topics include: **Hemp Market Arbitrage:** The 2018 Farm Bill legalized hemp (cannabis with less than 0.3% THC), creating a loophole where companies extract and concentrate hemp-derived THC to match state-regulated potency levels. Hemp products avoid 280E tax restrictions, enable direct-to-consumer shipping, and allow social media advertising, making them significantly more profitable than state-regulated cannabis despite existing in a legal gray area.; **280E Tax Burden:** Cannabis companies cannot deduct business expenses under IRS code 280E because cannabis remains Schedule I, resulting in 70% effective tax rates versus typical corporate rates. Removing this restriction through federal rescheduling would make most cannabis businesses profitable overnight. State excise taxes add another 15-20% burden, pushing consumers toward illicit markets where California struggles with legal adoption..

How long is this episode of This Week in Startups?

This episode is 55 minutes long. SignalCast provides an AI-generated summary so you can get the key insights in about 3 minutes.

This Week in Startups

How decriminalization led to an explosion in cannabis startups (Feat. Ford Smith, Andrew Duffy, and Socrates Rosenfeld) | E2241

January 29, 2026

55 min episode · 2 min read

Ford Smith

Episode

55 min

Read time

2 min

Topics

Startups, Fundraising & VC, Marketing

AI-Generated Summary

Published Jan 29, 2026

Key Takeaways

✓Hemp Market Arbitrage: The 2018 Farm Bill legalized hemp (cannabis with less than 0.3% THC), creating a loophole where companies extract and concentrate hemp-derived THC to match state-regulated potency levels. Hemp products avoid 280E tax restrictions, enable direct-to-consumer shipping, and allow social media advertising, making them significantly more profitable than state-regulated cannabis despite existing in a legal gray area.
✓280E Tax Burden: Cannabis companies cannot deduct business expenses under IRS code 280E because cannabis remains Schedule I, resulting in 70% effective tax rates versus typical corporate rates. Removing this restriction through federal rescheduling would make most cannabis businesses profitable overnight. State excise taxes add another 15-20% burden, pushing consumers toward illicit markets where California struggles with legal adoption.
✓Market Consolidation Reality: Cannabis industry funding peaked in 2021 at over $70 billion but has declined sharply since. The market shifted from growth-at-all-costs to profitability requirements. Success now means survival rather than rapid scaling. Companies that raised heavily for state-regulated markets before pivoting to hemp face significant dilution, creating acquisition opportunities for strategic buyers entering during this uncertainty period before potential federal rescheduling.
✓Potency Regulation Gap: Prohibition and over-taxation drive consumers toward high-potency products to maximize value per dollar spent. Pre-regulation California sold 400-milligram edibles versus the recommended 5-10 milligram dose. Concentrate products like shatter contain 80-100% THC. Federal legalization would enable sensible potency caps similar to alcohol proof limits, protecting consumers while expanding the market to mainstream users currently deterred by extreme products.
✓Pesticide Testing Failures: LA Times testing revealed 70% of major California cannabis brands failed pesticide standards, with regulators checking only 66 pesticides while FDA tobacco regulations cover seven additional critical compounds. Industry response created ECHO certification, a nonprofit third-party auditing system. Labs found 90% of samples contained neem oil, which causes toxicity symptoms identical to reported cannabis-induced psychosis, suggesting contamination rather than THC causes adverse reactions.

What It Covers

Cannabis industry experts Ford Smith, Andrew Duffy, and Socrates Rosenfeld discuss the state of cannabis startups, regulatory challenges including Schedule I classification and 280E tax code, the hemp market loophole enabling national distribution, market consolidation since 2021, and prospects for federal rescheduling under Trump's second term affecting the $30 billion industry.

Key Questions Answered

•Hemp Market Arbitrage: The 2018 Farm Bill legalized hemp (cannabis with less than 0.3% THC), creating a loophole where companies extract and concentrate hemp-derived THC to match state-regulated potency levels. Hemp products avoid 280E tax restrictions, enable direct-to-consumer shipping, and allow social media advertising, making them significantly more profitable than state-regulated cannabis despite existing in a legal gray area.
•280E Tax Burden: Cannabis companies cannot deduct business expenses under IRS code 280E because cannabis remains Schedule I, resulting in 70% effective tax rates versus typical corporate rates. Removing this restriction through federal rescheduling would make most cannabis businesses profitable overnight. State excise taxes add another 15-20% burden, pushing consumers toward illicit markets where California struggles with legal adoption.
•Market Consolidation Reality: Cannabis industry funding peaked in 2021 at over $70 billion but has declined sharply since. The market shifted from growth-at-all-costs to profitability requirements. Success now means survival rather than rapid scaling. Companies that raised heavily for state-regulated markets before pivoting to hemp face significant dilution, creating acquisition opportunities for strategic buyers entering during this uncertainty period before potential federal rescheduling.
•Potency Regulation Gap: Prohibition and over-taxation drive consumers toward high-potency products to maximize value per dollar spent. Pre-regulation California sold 400-milligram edibles versus the recommended 5-10 milligram dose. Concentrate products like shatter contain 80-100% THC. Federal legalization would enable sensible potency caps similar to alcohol proof limits, protecting consumers while expanding the market to mainstream users currently deterred by extreme products.
•Pesticide Testing Failures: LA Times testing revealed 70% of major California cannabis brands failed pesticide standards, with regulators checking only 66 pesticides while FDA tobacco regulations cover seven additional critical compounds. Industry response created ECHO certification, a nonprofit third-party auditing system. Labs found 90% of samples contained neem oil, which causes toxicity symptoms identical to reported cannabis-induced psychosis, suggesting contamination rather than THC causes adverse reactions.

Notable Moment

One panelist revealed gas stations in Austin currently sell 100-milligram THC beverages through the hemp loophole, equivalent to 10-20 standard doses in a single drink. This unregulated market mirrors the Four Loko problem where consumers underestimate potency based on familiar packaging formats, demonstrating how lack of federal oversight creates dangerous products that threaten the industry's legitimacy and consumer safety.

Know someone who'd find this useful?

Episode Transcript

Way to look at this is it's it's going to force the best companies to emerge. We're gonna have to think creatively and resourcively like this industry has for decades. People will find a way to this plant. People will find a way to sell this plant, whether it's legal or not, whether the financial markets are backing it or not, because this plant helps millions and millions of people. I I think this is the next great American industry, period. Cannabis is a scheduled drug, but hemp is not a scheduled drug. It is a federally legal product. So when you jump into the federal hemp market and you can start shipping d to c and you can hack your way around, you know, meta and Snapchat to start running, you know, normal CPG type focused ads. It's a much more efficient business. It's true consumer packaged goods at that point. And so we decided to not go into that space because we thought it was a little too risky. We had a conservative investor base. It's a it felt a little gray area at the time. In hindsight, I wish we had done it because there's been a lot of brands that have done really well and quickly grabbed a lot of market share nationally. There's an insane amount of these brands on the shelves now. This Week in Startups is brought to you by Circle. Circle gives you everything you need to build and scale your community led business. Twist listeners get $1,000 off Circle's professional plan at circle.so/twist. Zite. Zite is the fastest way to build business software with AI. Build apps, forms, websites, and portals that connect to the tools that you already use. Go to zite.com/twist and get 50% off your first project. Gusto. Check out the online payroll and benefits experts with software built specifically for small businesses and startups. Try Gusto today and get three months free at gusto.com/twist. Alright, everybody. Welcome back to Twist. Today is Wednesday, January 28. We've got a great show for you today. We're gonna be talking about the cannabis industry with three experts and specifically around startups, the opportunity there, and the changing legislation and regulation in the industry. But before we get to that very important note, I wanted to give a little memorial here to a friend of mine, Herman Kotler. Herman, like me, was a kid from Brooklyn, him from Bed Stearns, me from Bay Ridge. He was also the father of Matt Kotler, who has been my partner here at launch and this week in startups, for many years. But Herman was a bit of a storyteller, also from Brooklyn, as I mentioned. May or may not have been in a foreign three letter agency, may have worked for the government. I'm not saying that those rumors haven't happened around me as well. But Herman and I would get together once in a while and talk about his son, Matt, who we …

Get the full transcript (10,464 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all This Week in Startups transcripts →